STAT

Opinion: You need a new kidney to stay alive. Would you reject one from someone who died of a drug overdose?

By viewing organ donors who died of #opioid overdoses as victims of a disease, we could honor them for their precious gifts of life, just as we honor every other…

It’s hard to fathom any goodness coming from the opioid crisis and the family tragedies it causes every day. But it does, in the form of an increase in organs available to people who need new hearts, livers, kidneys, and other organs.

By their ages only, many of those dying of overdoses would be considered in the prime of life. Their organs have years of vitality left, and can give the thousands of Americans on organ wait lists the chance for new lives.

We specialize in kidney transplantation. In the United States, are performed each year, too slow a pace for the 95,000 Americans waiting for new kidneys. Getting a donor kidney is a yearslong wait, and thousands succumb to kidney failure each year before a potential match becomes available.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks